[9], who have shown that the breast cancer stem cell phenotypes of (a) CD44+/CD24−/low phenotype and (b) the overexpression of aldehyde dehydrogenase 1 (ALDH1+) are able to form tumors in mice with high tumorigenic capacity. This evidence concerns the gene CD44 and breast cancer.